Ongoing Studies @ Bluestone
Oral Leukoplakia
Do you have red or white spots on your tongue or in your mouth?
The purpose of this study is to evaluate how a product made from soybeans named Bowman-Birk Inhibitor Concentrate (BBIC) affects white or red patches in your mouth (oral leukoplakia). BBIC is derived from soybeans and belongs to a class of compounds known as protease-inhibitors. *
Some experimental data suggests that soybean derived protease-inhibitors have a strong effect against cancer in animals. The exact mechanism by which this works is unclear. The study will also look at any side effects when taking this study medication. * How to participate: If you are interested in participating in this study, you can contact our Chief Clinical Research Coordinator Margaret Andrew at 212-998-9626 or the Principal investigator of this study, Dr. Ross Kerr at 212-998-9885.
Study Status: This study is ongoing and open for enrolment. Study Background: Leukoplakia is a common, potentially pre-cancerous disease of the mouth that involves the formation of red or white spots on the tongue and inside the mouth. Despite the increased risk associated with having leukoplakia, many people with this condition never develop oral cancer. Interested?
If you would like to receive more information about this study, you can contact our research center by using our contact form. The principal investigator of this study or the study coordinator will contact you soon.
Top of Page | Previous Page
|
